| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Final results of the TANIA randomized phase III trial of bevacizumab (BEV) after progression on 1st-line BEV therapy for HER2-negative locally recurrent/metastatic breast cancer (LR/mBC) |
| Type de publication | Journal Article |
| Year of Publication | 2016 |
| Auteurs | Vrdoljak E., Marschner N., Zielinski C., Gligorov J., Cortes J., Puglisi F., Aapro M., Fallowfield L., Fontana A., Inbar M., Kahan Z., Welt A., Levy C., Brain E., Pivot X., Putzu C., Gonzalez-Martin A., Ebel K., Easton V., von Minckwitz G. |
| Journal | CANCER RESEARCH |
| Volume | 76 |
| Date Published | FEB 15 |
| Type of Article | Meeting Abstract |
| ISSN | 0008-5472 |
| DOI | 10.1158/1538-7445.SABCS15-P6-14-01 |
